APA (7th ed.) Citation

Y, J., W, Z., H, W., Z, Z., C, C., X, L., & Q, Z. (2026). [Retracted] EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P‑gp substrates in vitro and in vivo. Oncology reports, 55(4), . https://doi.org/10.3892/or.2026.9066

Chicago Style (17th ed.) Citation

Y, Jin, Zhang W, Wang H, Zhang Z, Chu C, Liu X, and Zou Q. "[Retracted] EGFR/HER2 Inhibitors Effectively Reduce the Malignant Potential of MDR Breast Cancer Evoked by P‑gp Substrates in Vitro and in Vivo." Oncology Reports 55, no. 4 (2026). https://doi.org/10.3892/or.2026.9066.

MLA (9th ed.) Citation

Y, Jin, et al. "[Retracted] EGFR/HER2 Inhibitors Effectively Reduce the Malignant Potential of MDR Breast Cancer Evoked by P‑gp Substrates in Vitro and in Vivo." Oncology Reports, vol. 55, no. 4, 2026, https://doi.org/10.3892/or.2026.9066.